Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 86Unknown 54Recruiting 40Terminated 25Not yet recruiting 20Active not recruiting 17Withdrawn 12Suspended 2Enrolling by invitation 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Breast 2

Conditions

Clinical Stage I Gastric Cancer AJCC v8 1Carcinoma, Hepatocellular 1

Interventions

Drug Therapy 4Cisplatin 4Chemoradiotherapy 4lenvatinib 3camrelizumab 3Specimen Handling 3Paclitaxel 3Oxaliplatin 3Carboplatin 3toripalimab 2Surgical Procedures, Operative 2Standard of Care 2Radiotherapy 2Patient Navigation 2Methods 2Leucovorin 2Laparoscopy 2Fluorouracil 2Fluorodeoxyglucose F18 2Educational Status 2Early Intervention, Educational 2Capecitabine 2Biopsy 2Bevacizumab 2130-nm albumin-bound paclitaxel 2tislelizumab 1sintilimab 1pembrolizumab 1nimotuzumab 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Surgical Procedures, Operative × Gastrointestinal × Clear all
NCT07139951 2025-12-31

HORIZON

Mayo Clinic

Phase 2 Enrolling by invitation
16 enrolled
Gastrointestinal

Clinical Stage I Gastric Cancer AJCC v8

NCT07290764 2025-12-18

Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy

Fujian Provincial Hospital

Enrolling by invitation
729 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡